Shopping Cart
- Remove All
- Your shopping cart is currently empty
Thalidomide-O-C7-acid is a compound synthesized as an E3 ligase ligand-linker conjugate, consisting of a cereblon ligand derived from Thalidomide and a linker commonly used in PROTAC technology.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $494 | 35 days |
Description | Thalidomide-O-C7-acid is a compound synthesized as an E3 ligase ligand-linker conjugate, consisting of a cereblon ligand derived from Thalidomide and a linker commonly used in PROTAC technology. |
In vitro | PROTACs consist of two distinct ligands linked together: one binds to an E3 ubiquitin ligase, and the other to the target protein. They utilize the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
Alias | Thalidomide-O-C7-acid |
Molecular Weight | 416.43 |
Formula | C21H24N2O7 |
Cas No. | 2169266-70-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.